The Decade of Vaccine Economics (DOVE) team has conducted a cost-of-illness study in Uganda, generating cost estimates from the public healthcare system’s perspectives, the caregivers, and society. Most measles patients in Uganda use public healthcare facilities to treat its episodes for hospitalized and ambulatory care, followed by private not-for-profit facilities. A significant proportion of households of all socio-economic status experience catastrophic health expenditures related to measles, with the poorest households most at risk. In 2018, 2614 cases of measles were confirmed in Uganda, resulting in $135,627 in societal costs, including $59,357 in economic costs to Ugandan households.
The study evaluates the cost estimates that cover the use of the public, private for-profit, and private not-for-profit healthcare facilities from all levels of care in urban and rural areas.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.